Canada’s Federal Court of Appeal Limits Damages Available to Delayed Generics

June 08, 2009

Tags:

Food and Drug Regulatory Intellectual Property Intellectual Property Litigation Patents Pharmaceuticals

Related Expertise

Related Insights

Back